Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to...
Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
About this item
Full title
Author / Creator
Durante-Mangoni, Emanuele , Signoriello, Giuseppe , Andini, Roberto , Mattei, Annunziata , De Cristoforo, Maria , Murino, Patrizia , Bassetti, Matteo , Malacarne, Paolo , Petrosillo, Nicola , Galdieri, Nicola , Mocavero, Paola , Corcione, Antonio , Viscoli, Claudio , Zarrilli, Raffaele , Gallo, Ciro and Utili, Riccardo
Publisher
Oxford: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
Oxford: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Background. Extensively drug-resistant (XDR) Acinetobacter baumannii may cause serious infections in critically ill patients. Colistin often remains the only therapeutic option. Addition of rifampicin to colistin may be synergistic in vitro. In this study, we assessed whether the combination of colistin and rifampicin reduced the mortality of XDR A...
Alternative Titles
Full title
Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1399057234
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1399057234
Other Identifiers
ISSN
1058-4838
E-ISSN
1537-6591
DOI
10.1093/cid/cit253
